| 项目编号 |
PRJCA026539 |
| 项目标题 |
A Study of HQP1351 in Patients With GIST or Other Solid Tumors |
| 涉及领域 |
Medical |
| 数据类型 |
Whole genome sequencing
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
A phase I study to assess the safety, tolerability, pharmacokinetic and pharmacodynamic properties of oral olverembatinib in patients with GIST or other solid tumors. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2025-05-08 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 41184234
|
Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research
|
Signal Transduction and Targeted Therapy
|
10.1038/s41392-025-02456-9
|
2025
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| Guangzhou HealthQuest Pharma Co Ltd Inc.
|
|
N/A
|
|
|
|
| 提交者 |
Yifan
Zhai (yzhai@ascentage.com)
|
| 提交单位 |
Ascentage Pharma (Suzhou) Co., Ltd |
| 提交日期 |
2024-05-28 |
